Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (251-260 of 293) with videos related to

Pageof 30
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Plos One|November 1, 2023
Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, AustraliaNila J Dharan, Sarah C Sasson, Golo Ahlenstiel, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg LossSimon J Hume, Samuel Hall, Gareth Burns, et al.
BMC Infectious Diseases|November 18, 2025
A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C studySamira Hosseini-Hooshyar, Heather Valerio, Erin Flynn, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
The Lancet. Public Health|March 25, 2023
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort studyCas J Isfordink, Anders Boyd, Rachel Sacks-Davis, et al.
The Lancet. HIV|October 2, 2015
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trialJürgen K Rockstroh, Mark Nelson, Christine Katlama, et al.
The American Journal of Cardiology|December 31, 1997
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registryR Waksman, J J Popma, E D Kennard, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Pageof 30

Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
Plos One|November 1, 2023
Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, AustraliaNila J Dharan, Sarah C Sasson, Golo Ahlenstiel, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg LossSimon J Hume, Samuel Hall, Gareth Burns, et al.
BMC Infectious Diseases|November 18, 2025
A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C studySamira Hosseini-Hooshyar, Heather Valerio, Erin Flynn, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
The Lancet. Public Health|March 25, 2023
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort studyCas J Isfordink, Anders Boyd, Rachel Sacks-Davis, et al.
The Lancet. HIV|October 2, 2015
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trialJürgen K Rockstroh, Mark Nelson, Christine Katlama, et al.
The American Journal of Cardiology|December 31, 1997
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registryR Waksman, J J Popma, E D Kennard, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Pageof 30